Chenguang Biotech Group Co Ltd
SZSE:300138
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.09
14.99
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Chenguang Biotech Group Co Ltd
Interest Income Expense
Chenguang Biotech Group Co Ltd
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Chenguang Biotech Group Co Ltd
SZSE:300138
|
Interest Income Expense
-ÂĄ18.4m
|
CAGR 3-Years
-133%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-9%
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Interest Income Expense
ÂĄ771.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Interest Income Expense
ÂĄ733m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
21%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Interest Income Expense
ÂĄ1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Interest Income Expense
-ÂĄ2.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-36%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Interest Income Expense
-ÂĄ501.3m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Chenguang Biotech Group Co Ltd
Glance View
Chenguang Biotech Group Co., Ltd. engages in natural plant extractions. The company is headquartered in Handan, Hebei and currently employs 1,757 full-time employees. The company went IPO on 2010-11-05. The Company’s products include pigment, spices, supplement and medicine products, cottonseed products and others. The firm distributes its products in domestic and to overseas markets.
See Also
What is Chenguang Biotech Group Co Ltd's Interest Income Expense?
Interest Income Expense
-18.4m
CNY
Based on the financial report for Sep 30, 2025, Chenguang Biotech Group Co Ltd's Interest Income Expense amounts to -18.4m CNY.
What is Chenguang Biotech Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-9%
Over the last year, the Interest Income Expense growth was 56%. The average annual Interest Income Expense growth rates for Chenguang Biotech Group Co Ltd have been -133% over the past three years , 19% over the past five years , and -9% over the past ten years .